Table 2 Characteristics of patients with serous epithelial ovarian cancer broken down by FAK abundance
From: Ambivalent role of pFAK-Y397 in serous ovarian cancer-a study of the OVCAD consortium
n = 179 | FAK-low | FAK-high |  |  |
|---|---|---|---|---|
Characteristics | n = 14 (%) | n = 165 (%) | p | Adjusted p |
Age [mean +/− SD] | 56.1 [18.7] | 57.8 [11.9] | 0.645 |  |
FIGO | Â | Â | 0.150 | Â |
  II (n = 7) | 1 (7.1) | 6 (3.6) |  |  |
  III (n = 142) | 13 (92.9) | 129 (78.2) |  |  |
  IV (n = 30) | 0 (0) | 30 (18.2) |  |  |
Grade (1 missing) | Â | Â | 0.535 | Â |
  Grade 1&2 (n = 49) | 5 (35.7) | 44 (26.8) |  |  |
  Grade 3 (n = 129) | 9 (64.3) | 120 (73.2) |  |  |
Residual tumor | Â | Â | 0.082 | Â |
  no (n = 126) | 7 (50.0) | 119 (72.1) |  |  |
  > 0 cm (n = 53) | 7 (50.0) | 46 (27.9) |  |  |
Peritoneal carcinomatosis | Â | Â | 0.539 | Â |
  no (n = 50) | 5 (35.7) | 45 (27.3) |  |  |
  yes (n = 129) | 9 (64.3) | 120 (72.7) |  |  |
Ascites | Â | Â | 0.869 | Â |
  </= 500 ml (n = 106) | 8 (57.1) | 98 (59.4) |  |  |
  > 500 ml (n = 73) | 6 (42.9) | 67 (40.6) |  |  |
pNM | Â | Â | 0.031 | 0.217 |
  N0 and M0 (n = 20) | 4 (28.5) | 16 (9.8) |  |  |
  N1 and/or M1 (n = 111) | 5 (35.7) | 106 (64.6) |  |  |
  NX or MX* (n = 48) | 5 (35.7) | 42 (25.6) |  |  |